BR112022016589A2 - COMPOSITION COMPRISING 2?-FL AND DFL FOR USE IN A METHOD TO REDUCE PAIN - Google Patents

COMPOSITION COMPRISING 2?-FL AND DFL FOR USE IN A METHOD TO REDUCE PAIN

Info

Publication number
BR112022016589A2
BR112022016589A2 BR112022016589A BR112022016589A BR112022016589A2 BR 112022016589 A2 BR112022016589 A2 BR 112022016589A2 BR 112022016589 A BR112022016589 A BR 112022016589A BR 112022016589 A BR112022016589 A BR 112022016589A BR 112022016589 A2 BR112022016589 A2 BR 112022016589A2
Authority
BR
Brazil
Prior art keywords
dfl
composition
reduce pain
pain
reduce
Prior art date
Application number
BR112022016589A
Other languages
Portuguese (pt)
Inventor
Mcconnell Bruce
Kristine Vigsnaes Louise
Bergonzelli Degonda Gabriela
Favre Laurent
Ferrier Laurent
Lucia Garcia-Rodenas Clara
Original Assignee
Glycom As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/706,627 external-priority patent/US20200138838A1/en
Application filed by Glycom As filed Critical Glycom As
Publication of BR112022016589A2 publication Critical patent/BR112022016589A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Abstract

COMPOSIÇÃO QUE COMPREENDE 2’-FL E DFL PARA USO EM UM MÉTODO PARA REDUZIR A DOR. O pedido refere-se a composições sintéticas contendo 2?-FL e DFL e métodos para reduzir a dor e/ou a percepção de dor visceral em um humano não infantil.COMPOSITION COMPRISING 2-FL AND DFL FOR USE IN A METHOD TO REDUCE PAIN. The application relates to synthetic compositions containing 2'-FL and DFL and methods for reducing pain and/or perception of visceral pain in a non-infant human.

BR112022016589A 2019-12-06 2020-12-07 COMPOSITION COMPRISING 2?-FL AND DFL FOR USE IN A METHOD TO REDUCE PAIN BR112022016589A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA201901439 2019-12-06
US16/706,627 US20200138838A1 (en) 2014-10-29 2019-12-06 Composition comprising hmss/hmos and use thereof
PCT/IB2020/061578 WO2021111422A1 (en) 2019-12-06 2020-12-07 Composition comprising 2'-fl and dfl for use in a method for reducing pain

Publications (1)

Publication Number Publication Date
BR112022016589A2 true BR112022016589A2 (en) 2022-10-11

Family

ID=76222486

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022016589A BR112022016589A2 (en) 2019-12-06 2020-12-07 COMPOSITION COMPRISING 2?-FL AND DFL FOR USE IN A METHOD TO REDUCE PAIN

Country Status (3)

Country Link
EP (1) EP4076474A4 (en)
BR (1) BR112022016589A2 (en)
WO (1) WO2021111422A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024042235A1 (en) * 2022-08-25 2024-02-29 Dsm Ip Assets B.V. Hybrid method for producing complex hmos

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2822500C (en) * 2010-12-31 2022-07-26 Abbott Laboratories Human milk oligosaccharides to promote growth of beneficial bacteria
EP2670399A4 (en) * 2011-02-04 2015-08-26 Univ California Disialyllacto-n-tetraose (dslnt) or variants, isomers, analogs and derivatives thereof to prevent or inhibit bowel disease
US10314852B2 (en) * 2014-10-24 2019-06-11 Glycom A/S Mixtures of HMOs
WO2016066175A1 (en) * 2014-10-29 2016-05-06 Glycom A/S Synthetic composition and method for treating irritable bowel syndrome
US20230338403A1 (en) * 2014-10-29 2023-10-26 Glycom A/S Composition comprising 2'-fl and dfl for use in a method for reducing pain
US11432578B2 (en) * 2015-12-15 2022-09-06 Glycom A/S Mixture of HMOs
ES2924137T3 (en) * 2016-05-05 2022-10-04 Glycom As Composition comprising HMOS for use in the treatment of hypersensitivity and/or visceral pain mediated by mast cells
CA3059265A1 (en) * 2017-04-07 2018-10-11 Children's Hospital Medical Center Treatment of inflammatory bowel diseases with 2'-fucosyllactose compounds
US11291677B2 (en) * 2017-05-09 2022-04-05 Glycom A/S Synthetic composition for microbiota modulation
CN111683666A (en) * 2017-12-22 2020-09-18 格礼卡姆股份公司 Compositions comprising HMOs for preventing or reducing nociception
EP4068992A1 (en) * 2019-12-06 2022-10-12 Société des Produits Nestlé S.A. Compositions for use in the reduction of pain and/or perception of pain in infants and young children

Also Published As

Publication number Publication date
EP4076474A4 (en) 2024-02-28
WO2021111422A1 (en) 2021-06-10
EP4076474A1 (en) 2022-10-26

Similar Documents

Publication Publication Date Title
ATE526942T1 (en) HYDROACOHOLIC ANTIMICROBIAL COMPOSITION WITH HEALTHY SKIN BENEFITS
BR112018069220A2 (en) use of polypeptide that has dnase activity for tissue treatment
PH12016502254A1 (en) Keratin treatment formulations and methods
BR0317088A (en) Breathable multilayer films for use in absorbent products
BRPI0407375A (en) Methods for treating pain by administering a neural growth factor antagonist and a nsaid and compositions containing same
MX2020009313A (en) Compositions and methods for skin renewal.
BR112018007560A2 (en) cosmetic composition having probiotic bacteria
BR112014009785A8 (en) method to treat or reduce vet
BR112013001301A2 (en) a process for preparing a liquid pharmaceutical composition comprising human immunoglobulin g and a liquid pharmaceutical composition containing human immunoglobulin g
BR112015022650A2 (en) macrocyclic salt inducible kinase inhibitors
BR112021016296A2 (en) Topical formulations of rapamycin and their use in the treatment of facial angiofibromas and other skin disorders
MX2020002889A (en) A 19-nor c3,3-disubstituted c21-n-pyrazolyl steroid and methods of use thereof.
BR112015013374A2 (en) hemostatic glove device and method for using it
BR112022016589A2 (en) COMPOSITION COMPRISING 2?-FL AND DFL FOR USE IN A METHOD TO REDUCE PAIN
MX368750B (en) Oil based semisolid pharmaceutical compositions containing pirfenidone for application in tissue repair.
ES2895910T3 (en) Multiphase compositions
UY36099A (en) LAQUINIMOD FOR THE TREATMENT OF PATIENTS WITH MULTIPLE RECURRENT MULTIPLE SCLEROSIS (RRMS) WITH A HIGH DEGREE OF DISABILITY
BR112019004413A2 (en) method for creating a pattern in a natural material of human or animal origin, natural material of human or animal origin, and use of a natural material.
DE59403803D1 (en) USE OF CORRINOIDS FOR TOPICAL APPLICATION IN SKIN DISEASES
BRPI0907224A2 (en) narcotic emulsion formulations for surgical pain treatment
MX2017007129A (en) Deodorant emulsion containing a mixture of alkylpolyglycoside and fatty alcohol, an associative nonionic polyurethane polyether, a volatile hydrocarbon-based oil.
BR112014025973A2 (en) preparation and method for preventing and treating osteoporosis and bone fractures
SG11201909144VA (en) Bacterial secretome for use in the treatment of skin lesions
BR112015022475A8 (en) liquid formulation and method for preventing oxidation of a protein in a protein formulation
UY39061A (en) RIP2-KINASE MACROCYCLIC INHIBITORS